Abatacept Drug Aliquot | Anti-CD80, CD86 | Therapeutic Fusion Protein Abatacept Aliquots of the reference drug Abatacept are now available as research consumables.
Adalimumab Biosimilar Drug Aliquot | Anti-TNF-α | Therapeutic Antibody Adalimumab Aliquots of the biosimilar Adalimumab (Yuflyma®) are now available as research consumables.
Adalimumab Biosimilar Drug Aliquot | Anti-TNF-α | Therapeutic Antibody Adalimumab Aliquots of the biosimilar Adalimumab (Hukyndra®) are now available as research consumables.
Adalimumab Biosimilar Drug Aliquot | Anti-TNF-α | Therapeutic Antibody Adalimumab Aliquots of the biosimilar Adalimumab (Idacio®) are now available as research consumables.
Adalimumab Biosimilar Drug Aliquot | Anti-TNF-α | Therapeutic Antibody Adalimumab Aliquots of the biosimilar Adalimumab (Hyrimoz®) are now available as research consumables.
Adalimumab Biosimilar Drug Aliquot | Anti-TNF-α | Therapeutic Antibody Adalimumab Aliquots of the biosimilar Adalimumab (Hulio®) are now available as research consumables.
Adalimumab Biosimilar Drug Aliquot | Anti-TNF-α | Therapeutic Antibody Adalimumab Aliquots of the biosimilar Adalimumab (Imraldi®) are now available as research consumables.
Adalimumab Biosimilar Drug Aliquot | Anti-TNF-α | Therapeutic Antibody Adalimumab Aliquots of the biosimilar Adalimumab (Amgevita®) are now available as research consumables.
Adalimumab Drug Aliquot | Anti-TNF-α | Therapeutic Antibody Adalimumab Aliquots of the reference drug Adalimumab (Humira®) are now available as research consumables.
Aflibercept Drug Aliquot | Anti-VEGF-A/PIGF | Therapeutic Fusion Protein Aflibercept Aliquots of the reference drug Aflibercept are now available as research consumables.
Albutrepenonacog Alfa Drug Aliquot | Coagulation Factor IX | Therapeutic Fusion Protein Albutrepenonacog Alfa Aliquots of the reference drug Albutrepenonacog Alfa are now available as research consumables.
Aldesleukin Drug Aliquot | Anti-IL2 R | Therapeutic Cytokine Aldesleukin Aliquots of the reference drug Aldesleukin are now available as research consumables.
Alemtuzumab Drug Aliquot | Anti-CD52 | Therapeutic Antibody Alemtuzumab Aliquots of the reference drug Alemtuzumab are now available as research consumables.
Alglucosidase alfa Drug Aliquot | Anti Lysosomal glycogen | Therapeutic Enzyme Alglucosidase alfa Aliquots of the original Alglucosidase alfa (Myozyme®) are now available as research consumables.
Alteplase Drug Aliquot | Plasminogen activator (rt-PA) | Therapeutic Glycoprotein Alteplase Aliquots of the reference drug Alteplase are now available as research consumables.
Amivantamab Drug Aliquot | Anti-EGFR/MET | Therapeutic Bispecific Antibody Amivantamab Aliquots of the reference drug Amivantamab are now available as research consumables.
Atezolizumab Drug Aliquot | Anti-PD-L1 | Therapeutic Antibody Atezolizumab Aliquots of the reference drug Atezolizumab are now available as research consumables.
Avalglucosidase alfa Drug Aliquot | Anti Lysosomal glycogen | Therapeutic Enzyme Avalglucosidase alfa Aliquots of the original Avalglucosidase alfa are now available as research consumables.
Avelumab Drug Aliquot | Anti-PD-L1 | Therapeutic Antibody Avelumab Aliquots of the reference drug Avelumab are now available as research consumables.
Belatacept Drug Aliquot | Anti-CD80/CD86 | Therapeutic Fusion Protein Belatacept Aliquots of the reference drug Belatacept (Nulojix®) are now available as research consumables.
Bevacizumab Drug Aliquot | Anti-VEGF-A | Therapeutic Antibody Bevacizumab Aliquots of the reference drug Bevacizumab (Avastin®) are now available as research consumables.
Blinatumomab Drug Aliquot | Anti-CD19, CD3 | Therapeutic Bi-specific T-cell engager Blinatumomab Aliquots of the reference drug Blinatumomab are now available as research consumables.
Brentuximab Vedotin Drug Aliquot | Anti-CD30 | Therapeutic ADC Brentuximab Vedotin Aliquots of the reference drug Brentuximab Vedotin are now available as research consumables.
Brodulamab Drug Aliquot | Anti-IL-17RA | Therapeutic Antibody Brodalumab Aliquots of the reference drug Brodalumab are now available as research consumables.
Canakinumab Drug Aliquot | Anti-IL1 beta | Therapeutic Antibody Canakinumab Aliquots of the original Canakinumab (Ilaris®) are now available as research consumables.
Certolizumab Pegol Drug Aliquot | Anti TNF-α | Therapeutic ADC Certolizuman Pegol Aliquots of the reference drug Certolizumab Pegol are now available as research consumables.
Cetuximab Drug Aliquot | Anti-EGFR | Therapeutic Antibody Cetuximab Aliquots of the reference drug Cetuximab are now available as research consumables.
Daratumumab Drug Aliquot | Anti-CD38 | Therapeutic Antibody Daratumumab Aliquots of the reference drug Daratumumab are now available as research consumables.
Denosumab Drug Aliquot | Anti-RANKL | Therapeutic Antibody Denosumab Aliquots of the reference drug Denosumab are now available as research consumables.
Dornase Alfa Drug Aliquot | DNA in Cystic fibrosis mucus | Therapeutic Enzyme Dornase Alfa Aliquots of the reference drug Dornase Alfa are now available as research consumables.
Dulaglutide Drug Aliquot | Anti-GLP-1| Therapeutic Hormone Dulaglutide Aliquots of the reference drug Dulaglutide are now available as research consumables.
Dupilumab Drug Aliquot | Anti-IL13/IL4 | Therapeutic Antibody Dupilumab Aliquots of the reference drug Dupilumab (Dupixent®) are now available as research consumables.
Durvalumab Drug Aliquot | Anti-PD-L1 | Therapeutic Antibody Durvalumab Aliquots of the reference drug Durvalumab are now available as research consumables.
Eculizumab Drug Aliquot | Anti-C5 complement protein | Therapeutic Antibody Eculizumab Aliquots of the reference drug Eculizumab are now available as research consumables.
Elotuzumab Drug Aliquot | Anti-SLAM7 | Therapeutic Antibody Elotuzumab Aliquots of the reference drug Elotuzumab are now available as research consumables.
Emicizumab Drug Aliquot | Anti-Clotting Factor IXa and X | Therapeutic Bispecific Antibody Emicizumab Aliquots of the reference drug Emicizumab are now available as research consumables.
Enfortumab Vedotin Drug Aliquot | Anti-Nectin-4 | Therapeutic ADC Enfortumab Vedotin Aliquots of the reference drug Enfortumab Vedotin are now available as research consumables.
Epoetin Zeta Drug Aliquot | Anti-EPO receptor | Therapeutic Glycoprotein Hormone Epoetin Zeta Aliquots of the biosimilar Epoetin Zeta are now available as research consumables.
Etanercept Biosimilar Drug Aliquot | Anti TNF-α | Therapeutic Fusion Protein Etanercept Aliquots of the biosimilar drug Etanercept (Erelzi®) are now available as research consumables.
Etanercept Biosimilar Drug Aliquot | Anti-TNF-α | Therapeutic Fusion Protein Etanercept Aliquots of the biosimilar drug Etanercept (Benepali®) are now available as research consumables.
Etanercept Biosimilar Drug Aliquot | Anti TNF-α | Therapeutic Fusion Protein Etanercept Aliquots of the biosimilar drug Etanercept (Nepexto®) are now available as research consumables.
Etanercept Drug Aliquot | Anti-TNF-α | Therapeutic Fusion Protein Etanercept Aliquots of the reference drug Etanercept (Enbrel®) are now available as research consumables.
Evolocumab Drug Aliquot | Anti-PCSK9 | Therapeutic Antibody Evolocumab Aliquots of the original Evolocumab (Repatha®) are now available as research consumables.
Galsulfase Drug Aliquot | Anti-CGRP | Therapeutic Enzyme Galsulfase Aliquots of the reference drug Galsulfase are now available as research consumables.
Gemtuzumab Ozogamicin Drug Aliquot | Anti-CD33 | Therapeutic ADC Gemtuzumab Ozogamicin Aliquots of the reference drug Gemtuzumab Ozogamicin (Mylotarg®) are now available as research consumables.
Golimumab Drug Aliquot | Anti-TNF-α | Therapeutic Antibody Golimumab Aliquots of the reference drug Golimumab are now available as research consumables.
Guselkumab Drug Aliquot | Anti-IL23 | Therapeutic Antibody Guselkumab Aliquots of the reference drug Guselkumab (Tremfya®) are now available as research consumables.
Infliximab Biosimilar Drug Aliquot | Anti-TNF-α | Therapeutic Antibody Infliximab Aliquots of the biosimilar Infliximab (Flixabi®) are now available as research consumables.
Infliximab Biosimilar Drug Aliquot | Anti-TNF-α | Therapeutic Antibody Infliximab Aliquots of the biosimilar Infliximab (Zessly®) are now available as research consumables.
Infliximab Drug Aliquot | Anti-TNF-α | Therapeutic Antibody Infliximab Aliquots of the reference drug Infliximab (Remicade®) are now available as research consumables.
Ipilimumab Drug Aliquot | Anti-CTLA-4 | Therapeutic Antibody Ipilimumab Aliquots of the reference drug Ipilimumab (Yervoy®) are now available as research consumables.
Ixekizumab Drug Aliquot | Anti-IL-17A, IL-17A/F | Therapeutic Antibody Ixekizumab Aliquots of the reference drug Ixekizumab are now available as research consumables.
Luspatercept Drug Aliquot | Anti-TGF-beta | Therapeutic Fusion Protein Luspatercept Aliquots of the reference drug Luspatercept (Reblozyl®) are now available as research consumables.
Mogamulizumab Drug Aliquot | Anti-CCR4 | Therapeutic Antibody Mogamulizumab Aliquots of the reference drug Mogamulizumab are now available as research consumables.
Natalizumab Drug Aliquot | Alpha-4 integrin | Therapeutic Antibody Natalizumab Aliquots of the reference drug Natalizumab are now available as research consumables.
Nivolumab Drug Aliquot | Anti-PD-1 | Therapeutic Antibody Nivolumab Aliquots of the reference drug Nivolumab are now available as research consumables.
Obinutuzumab Drug Aliquot | Anti-CD20 | Therapeutic Antibody Obinutuzumab Aliquots of the reference drug Obinutuzumab are now available as research consumables.
Ocrelizumab Drug Aliquot | Anti-CD20 | Therapeutic Antibody Ocrelizumab Aliquots of the reference drug Ocrelizumab are now available as research consumables.
Octocog Alfa Drug Aliquot | Factor VIII | Therapeutic Recombinant protein Octocog Alfa Aliquots of the reference drug Octocog Alfa are now available as research consumables.
Omalizumab Original Drug Aliquot | Anti-IgE | Therapeutic Monoclonal Antibody Omalizumab Aliquots of the original drug Omalizumab (Xolair®) are now available as research consumables.
Palivizumab Drug Aliquot | Anti-RSVproteinF | Therapeutic Antibody Palivizumab Aliquots of the reference drug Palivizumab are now available as research consumables.
Panitumumab Drug Aliquot | Anti-EGFR | Therapeutic Antibody Panitumumab Aliquots of the original Panitumumab (Vectibix®) are now available as research consumables.
Pembrolizumab Drug Aliquot | Anti-PD-1 | Therapeutic Antibody Pembrolizumab Aliquots of the reference drug Pembrolizumab are now available as research consumables.
Pertuzumab Drug Aliquot | Anti-HER2 | Therapeutic Antibody Pertuzumab Aliquots of the reference drug Pertuzumab are now available as research consumables.
Polatuzumab Vedotin Drug Aliquot | Anti-CD79b | Therapeutic ADC Polatuzumab Vedotin Aliquots of the reference drug Polatuzumab Vedotin are now available as research consumables.
Ramucirumab Drug Aliquot | Anti-VEGFR2 | Therapeutic Antibody Ramucirumab Aliquots of the reference drug Ramucirumab are now available as research consumables.
Risankizumab Drug Aliquot | Anti-IL23 | Therapeutic Antibody Risankizumab Aliquots of the reference drug Risankizumab are now available as research consumables.
Rituximab Drug Aliquot | Anti-CD20 | Therapeutic Antibody Rituximab Aliquots of the reference drug Rituximab are now available as research consumables.
Romiplostim Drug Aliquot | Anti-TPO Receptor | Therapeutic Peptibody Romiplostim Aliquots of the reference drug Romiplostim are now available as research consumables.
Sacituzumab Govitecan Drug Aliquot | Anti-Trop-2 | Therapeutic ADC Sacituzumab Govitecan Aliquots of the reference drug Sacituzumab Govitecan are now available as research consumables.
Secukinumab Drug Aliquot | Anti-IL-17A | Therapeutic Antibody Secukinumab Aliquots of the reference drug Secukinumab are now available as research consumables.
Siltuximab Drug Aliquot | Anti-IL-6 | Monoclonal Antibody Siltuximab Aliquots of the reference drug Siltuximab are now available as research consumables.
Tocilizumab Drug Aliquot | Anti-IL-6R | Therapeutic Antibody Tocilizumab Aliquots of the reference drug Tocilizumab are now available as research consumables.
Trastuzumab Deruxtecan Drug Aliquot | Anti-HER2 | Therapeutic ADC Trastuzumab Deruxtecan Aliquots of the reference drug Trastuzumab Deruxtecan are now available as research consumables.
Trastuzumab Emtansine Drug Aliquot | Anti-HER2 | Therapeutic ADC Trastuzumab Emtansine Aliquots of the reference drug Trastuzumab Emtansine are now available as research consumables.
Trastuzumab Drug Aliquot | Anti-HER2 | Therapeutic Antibody Trastuzumab Aliquots of the reference drug Trastuzumab are now available as research consumables.
Ustekinumab Drug Aliquot | Anti-IL-12 | Therapeutic Antibody Ustekinumab Aliquots of the reference drug Ustekinumab are now available as research consumables.
Vedolizumab Drug Aliquot | Anti-α4β7integrin | Therapeutic Antibody Vedolizumab Aliquots of the reference drug Vedolizumab are now available as research consumables.
Velaglucerase Alfa Drug Aliquot | Anti-Glucosylceramidade | Therapeutic Enzyme Velaglucerase alfa Aliquots of the reference drug Velaglucerase alfa are now available as research consumables.